Chemical testing finds wide variation in synthetic THC products
HPLC-UV quantitation of synthetically derived THC, THCP, and HHC isomers in commercial vaping liquids and edibles (2019-2024).
AI Summary
This abstract-based laboratory study examined commercially available, synthetically derived THC products submitted for testing between 2019 and 2024. The researchers analyzed vaping liquids, dabs, gummies, and other candiesβnot people or animalsβand developed and validated high-performance liquid chromatography with ultraviolet detection (HPLC-UV) methods to measure seven THC positional isomers, along with THCP and HHC isomers. The study was analytical rather than a human safety or efficacy trial.
The tested products contained varied combinations of synthetic cannabinoid isomers. Total THC isomer concentrations ranged from 25β96% by weight in vaping liquids and dabs, while gummies contained 57β321 mg per gummy and other candy pieces contained 13β24 mg per piece. The highest reported concentration came from a combined THC/HHC product containing 649 mg of Ξ8-THC per gummy and 791 mg per gummy of total combined THC/HHC isomers. These results show substantial variation in cannabinoid composition and concentration among submitted commercial products. However, this abstract does not establish how representative the products were of the wider market, nor does it determine the productsβ effects, clinical risks, or the accuracy of labeling; reported adverse events were described as background rather than measured outcomes of this analysis.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Review finds mixed evidence on cannabis and tobacco co-use effects
Review finds promise in acidic cannabinoids, but human benefits remain unproven
A cancer-pain case report raises concern about THC/CBD with opioids
Explore More Research
Stay informed about the latest cannabis science.